Can a Brain Game Cut Your Dementia Risk? What the Evidence Actually Says

Can a brain game cut your dementia risk by 25 percent? There is no solid proof that it can, and the specific number people repeat rests on one much debated analysis rather than settled science. This is a serious medical topic, so it deserves a careful answer, and the honest one is that a hopeful figure has traveled much further than the evidence behind it.

Where does the dementia risk number come from?

It comes mainly from a single analysis of one large trial, which is important context that marketing usually leaves out. In 2017, Edwards and colleagues reported that a specific speed of processing exercise from the ACTIVE trial was associated with roughly a 29 percent lower risk of dementia over a ten year follow-up, and that striking figure is the likely source of the various percentages you see repeated online (Edwards et al., 2017). The crucial detail, however, is that dementia was not the primary outcome the ACTIVE trial was designed to measure, so this result came from a secondary analysis, which is a weaker form of evidence because the study was not built to answer that specific question in the first place.

Key takeaway: The dementia risk figure traces to one secondary analysis of a trial that was not designed to measure dementia, so it is a preliminary signal rather than proof.

Why is a secondary analysis not proof?

Because when a study looks for effects it was not designed to test, the result needs independent confirmation before anyone should rely on it. A secondary analysis can generate a promising hypothesis, yet it carries real limitations, including that the trial did not use dementia diagnosis as its main endpoint and that findings not planned in advance are more likely to reflect chance. This is the same reason we are cautious about single striking results in our article on whether brain training can make you smarter, where one exciting study did not survive later scrutiny. Until a finding like this is replicated in trials designed specifically to test it, describing it as a proven way to cut dementia risk overstates what is actually known.

Key takeaway: A secondary analysis can suggest a hypothesis but cannot confirm it, so a single unreplicated result should never be sold as proof that a game prevents dementia.

What have regulators already said about dementia claims?

They have already treated them as a serious problem, which is worth remembering before trusting any such promise. In 2016 the US Federal Trade Commission fined Lumos Labs, the maker of Lumosity, two million dollars, and the complaint specifically criticized the company for preying on fears about age related decline by suggesting its games could stave off memory loss and dementia without the science to support those claims (FTC, 2016). We discuss that case further in our article on whether brain training games actually work, and its lesson is direct, because a dementia claim is exactly the kind of promise that regulators have judged deceptive when the evidence was not there.

Key takeaway: Regulators have already penalized a brain game maker for implying its games could prevent dementia, which is a strong signal to distrust confident dementia risk claims.

The honest and responsible position

The responsible position is caution, both about the claim and about where you take real questions. No brain game has been shown to prevent dementia, and while the ACTIVE analysis is a genuine reason for continued research, it is not a reason to buy a product on the promise of a protected brain. Mentation reflects this directly, because it measures specific abilities such as reaction speed and memory against your own baseline and makes no claim to reduce dementia risk, and if you are worried about your memory or your long term brain health, the right step is a conversation with a qualified doctor rather than a game.

Not a medical device. For educational purposes only. If you are concerned about dementia or memory loss, please consult a qualified healthcare professional.